115 related articles for article (PubMed ID: 6311309)
1. [Effect of antioxidants of the 3-hydroxypyridine class on cyclic 3', 5'-adenosine monophosphate phosphodiesterase activity].
Smirnov LD; Malykhina LS; Lazarevich VG; Fedorov NA
Biull Eksp Biol Med; 1983 Sep; 96(9):40-2. PubMed ID: 6311309
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of platelet aggregation and cyclic nucleotide phosphodiesterase (specifically cyclAMP) by 3-hydroxypyridine derivatives].
Kagan VE; Polianskiĭ NB; Muranov KO; Shvedova AA; Smirnov LD
Biull Eksp Biol Med; 1984 Apr; 97(4):416-8. PubMed ID: 6202339
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by 2- or/and 8-substituted adenosine derivatives of adenosine deaminase and calmodulin-dependent phosphodiesterase.
Sasaki Y; Ono Y
Nucleic Acids Symp Ser; 1980; (8):s163-6. PubMed ID: 6265879
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of rat heart and brain cyclic 3',5'-adenosine monophosphate phosphodiesterase under the influence of neurohormone "C"].
Galoian AA; Gurvits BIa; Pogosian MA
Vopr Biokhim Mozga; 1976; 11():89-96. PubMed ID: 203105
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines].
Polyansky NB; Smirnov LD; Shvedova AA; Kagan VE; Tkachuk VA
Vopr Med Khim; 1983; 29(1):123-7. PubMed ID: 6301154
[TBL] [Abstract][Full Text] [Related]
6. Griseolic acid, an inhibitor of cyclic adenosine 3',5'-monophosphate phosphodiesterase. I. Taxonomy, isolation and characterization.
Nakagawa F; Okazaki T; Naito A; Iijima Y; Yamazaki M
J Antibiot (Tokyo); 1985 Jul; 38(7):824-9. PubMed ID: 2993218
[TBL] [Abstract][Full Text] [Related]
7. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries.
Bartel S; Tenor H; Krause EG
Biomed Biochim Acta; 1985; 44(5):K31-5. PubMed ID: 2415118
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP phosphodiesterase inhibition by coumarins and furanocoumarins.
Sardari S; Nishibe S; Horita K; Nikaido T; Daneshtalab M
Pharmazie; 1999 Jul; 54(7):554-6. PubMed ID: 10445247
[No Abstract] [Full Text] [Related]
9. Methyl 5'-(6-aminopurin-9-yl)-5'-deoxy-beta-D-ribofuranoside 2',3'-cyclic monophosphate: a novel, biologically active, structural analogue of cyclic AMP.
Nair V; Wiechert RJ; Vietti DE; Singh D; Stevens RH
J Cyclic Nucleotide Res; 1980; 6(3):189-200. PubMed ID: 6255019
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
Heyliger CE; Panagia V; Dhalla NS
J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP phosphodiesterase from human heart and drug action.
Tanaka T; Masuoka H; Ito M; Nakano T; Naka M; Hidaka H
Adv Second Messenger Phosphoprotein Res; 1992; 25():373-81. PubMed ID: 1313268
[No Abstract] [Full Text] [Related]
12. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids. II.
Nikaido T; Ohmoto T; Sankawa U; Tomimori T; Miyaichi Y; Imoto Y
Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):654-61. PubMed ID: 2842074
[No Abstract] [Full Text] [Related]
13. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
Chan SC; Hanifin JM
J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
[TBL] [Abstract][Full Text] [Related]
14. Tissue and species specificity of cardiac cAMP-phosphodiesterase inhibitors.
Pang DC
Adv Second Messenger Phosphoprotein Res; 1992; 25():307-20. PubMed ID: 1313264
[No Abstract] [Full Text] [Related]
15. [The seasonal rhythm of changes in adenosine cyclic monophosphate phosphodiesterase activity in the lymphocytes of human peripheral blood].
Kochetkova MN; Ozeretskovskaia NN; Ezhkova NG
Izv Akad Nauk SSSR Biol; 1988; (5):782-5. PubMed ID: 2849615
[No Abstract] [Full Text] [Related]
16. Inhibition of heart and brain cyclic adenosine 3',5'-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides.
Nemoz G; Prigent AF; Pacheco H
Biochem Pharmacol; 1978; 27(24):2769-74. PubMed ID: 216370
[No Abstract] [Full Text] [Related]
17. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by nicotinic acid [proceedings].
Saeed SA; Butt NM; Lovely JR; Collier HO
Biochem Soc Trans; 1979 Oct; 7(5):1042-4. PubMed ID: 229022
[No Abstract] [Full Text] [Related]
19. Inhibitors of adenosine 3',5'-cyclic monophosphate phosphodiesterase in Daphne genkwa Sieb. et Zucc.
Nikaido T; Ohmoto T; Sankawa U
Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):675-81. PubMed ID: 3036384
[No Abstract] [Full Text] [Related]
20. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
Koch HP; Bachner J; Löffler E
Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
